enVVeno Medical (NVNO) Non Operating Income (2017 - 2026)
enVVeno Medical's (NVNO) quarterly Non Operating Income came in at $213000.0 in Q1 2026, down 52.77% year-on-year from $451000.0 in Q1 2025, and down 23.1% quarter-over-quarter from $277000.0 in Q4 2025.
enVVeno Medical (NVNO) Non Operating Income (2017 - 2026) Analysis & Trends
enVVeno Medical's Non Operating Income history runs 10 years deep, the most recent figure standing at $213000.0 for Q1 2026.
- On a quarterly basis, Non Operating Income fell 52.77% year-over-year to $213000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 38.93% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 28.9% from the prior year.
- Non Operating Income eased to $213000.0 in Q1 2026 per NVNO's latest filing, from $277000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $629000.0 in Q4 2023 and bottomed at -$76000.0 in Q2 2022.
- The 5-year median for Non Operating Income is $348000.0 (2023), against an average of $331294.1.
- Across the five-year window, Non Operating Income tumbled 1050.0% in 2022 and soared 8000.0% in 2023, its largest moves.
- Year by year, Non Operating Income stood at $280000.0 in 2022, then jumped by 124.64% to $629000.0 in 2023, then slipped by 25.28% to $470000.0 in 2024, then tumbled by 41.06% to $277000.0 in 2025, then declined by 23.1% to $213000.0 in 2026.
- Per Business Quant, the three latest NVNO Non Operating Income figures stand at $213000.0 (Q1 2026), $277000.0 (Q4 2025), and $344000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | 213,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213,000.00 |
| Dec 31, 2025 | 277,000.00 |
| Sep 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 355,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 528,000.00 |
| Jun 30, 2024 | 498,000.00 |
| Mar 31, 2024 | 511,000.00 |
| Dec 31, 2023 | 629,000.00 |
| Sep 30, 2023 | 348,000.00 |
| Jun 30, 2023 | 340,000.00 |
| Mar 31, 2023 | 405,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | -76,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 318,000.00 |
| Jun 30, 2021 | 8,000.00 |